go-v.orgdoi

The anti-osteosarcoma effect from panax notoginseng saponins by inhibiting the G0 / G1 phase in the cell cycle and affecting p53-mediated autophagy and mitochondrial apoptosis

Guangtao Han, Yubiao Zhang, Ting Liu, Jianping Li, Haohuan Li · Journal of Cancer · 2021

  • DOI 10.7150/jca.54602
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2021

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2021

Abstract

Osteosarcoma is the most common primary bone malignancy, and current chemotherapy sessions against it often induce severe complications in patients.Thus, it is necessary to develop new and effective antineoplastic agents with fewer side effects.Panax notoginseng saponins (PNS) are the active components in panax notoginseng and were reported to be capable of inhibiting the growth of several tumors both in vitro and in vivo.However, its effects on osteosarcoma have not been studied yet, which is addressed in this study for the first time.Our results indicated that PNS can inhibit proliferation, invasion and migration of the osteosarcoma cells, while promoting their apoptosis simultaneously.Specifically, PNS caused an increase in mitochondrial membrane potential and the amount of reactive oxygen species.The cell cycle in osteosarcoma cells was arrested in the G0 / G1 phase after PNS treatment.The expression of p53 and other apoptosis-related mitochondrial proteins were promoted.Nevertheless, it was observed that autophagy became less active in osteosarcoma cells when PNS was administered.In a word, PNS were of potential therapeutic significance for osteosarcoma.

Open the resolved locator · 10.7150/jca.54602

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 20:54 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v12p6383.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.